The value of the global medtech market is expected to reach $477.5 billion by 2020, according life sciences market intelligence firm Evaluate Ltd. The “EvaluateMedTech World Preview 2015, Outlook to 2020” also states that worldwide medtech R&D expenditure is forecast to grow by 3.5 percent per annum to reach $29.5 billion by 2020. Other findings from the 2015 report:
- Worldwide medtech market forecast to grow more slowly than prescription drug market, with a CAGR of 4.1 percent between 2014 and 2020 versus 4.9 percent for pharma.
- Total medtech M&A deal values rose 166 percent to $84 billion in H1 2015.
- Medtronic’s $49.9 billion acquisition of Covidien in January 2015 was the biggest deal in medtech history.
- Johnson & Johnson held on to number one position in 2014 with medtech sales of $27.5 billion but Medtronic steals the top spot from 2015 onwards with a 2020 sales forecast of $34.9 billion.
The report can be downloaded at
http://www.evaluategroup.com/MedtechWP2015
.